Skip to content

MDMA: all studies

Page 322 of 345: studies 3,211 to 3,220 of 3,446, newest first. Back to the MDMA overview

Research

Consumption of new psychoactive substances in a Spanish sample of research chemical users.

Human Psychopharmacology: Clinical and Experimental July 1, 2013 Débora González, Mireia Ventura, Fernando Caudevilla et al. 39 citations

To know the pattern of use of new psychoactive substances (NPSs) in a Spanish sample of research chemical (RC) users and to deepen the RC user profile and risk reduction strategies employed. This study is a cross-sectional survey by means of a specific questionnaire. Recruitment was carried out at music festivals, at non-governmental organizations (NGOs), and through announcements on an online...

DOI: 10.1002/hup.2323 (opens in new tab) Full text (opens in new tab) 2c-b Consumption patterns New psychoactive substances Research chemicals +12

Effects of Schedule I drug laws on neuroscience research and treatment innovation.

Nature reviews. Neuroscience June 12, 2013 David Nutt, Leslie A. King, David E Nichols

Many psychoactive drugs are used recreationally, particularly by young people. This use and its perceived dangers have led to many different classes of drugs being banned under national laws and international conventions. Indeed, the possession of cannabis, 3,4-methylenedioxy-N-methylamphetamine (MDMA; also known as ecstasy) and psychedelics is stringently regulated. An important and...

DOI: 10.1038/nrn3530 (opens in new tab) Full text (opens in new tab) Animals Humans Psychotropic drugs Neurosciences +3

2C or not 2C: phenethylamine designer drug review.

Journal of Medical Toxicology June 2013 Be Vang Dean, Samuel J Stellpflug, Aaron M Burnett et al.

New groups of synthetic "designer drugs" have increased in popularity over the past several years. These products mimic the euphoric effects of other well-known illicit drugs but are advertised as "legal" highs and are sold over the internet, at raves and night clubs, and in head shops. The 2C series drugs are ring-substituted phenethylamines that belong to a group of designer agents similar in...

A survey of hallucinogenic mushroom use, factors related to usage, and perceptions of use among college students.

Drug and Alcohol Dependence June 1, 2013 Robert M. Hallock, Andrew Dean, Zachary A Knecht et al.

Recreational usage and attitudes toward psilocybin-containing hallucinogenic mushrooms among college students are seldom explored. We surveyed 882 randomly selected undergraduates at Skidmore College in upstate New York and quantified whether participants had ever used psilocybin mushrooms, their attitudes toward the drug, and polydrug use. There were 409 responses and 29.5% of the sample...

Novel Drugs of Abuse: A Snapshot of an Evolving Marketplace.

Adolescent Psychiatry April 1, 2013 Ryan Vandrey, Matthew W Johnson, Patrick S Johnson et al. 26 citations

Over the past decade, non-medical use of novel drugs has proliferated worldwide. In most cases these are synthetic drugs first synthesized in academic or pharmaceutical laboratories for research or drug development purposes, but also include naturally occurring substances that do not fit the typical pharmacological or behavioral profile of traditional illicit substances. Perhaps most unique to...

A Phenomenology of Hasidic Mysticism

University of Chicago Press eBooks March 29, 2013 Martina Urban

Buber regards hitlahavut as “the primal principle [Urprinzip] of Hasidic life.” Ekstase, Wonne (“bliss”), and Inbrunst (“fervor,” “ardor”) are synonyms employed to translate the term hitlahavut. Indeed, the words derived from the Hebrew root l-h-v (burning, flame, to be inflamed) evoke several of the central features attributed to Hasidic mysticism. Although hitlahavut “is the burning,” it is...

Additive inhibition of human α1β2γ2 GABAA receptors by mixtures of commonly used drugs of abuse.

Neurotoxicology March 2013 Laura Hondebrink, Sijie Tan, Elise Hermans et al.

Yearly, exposure to drugs of abuse results in ∼1 million emergency department visits in the US. In ∼50% of the visits, stimulant drugs like cocaine and amphetamine-like substances (e.g. 3,4-methylenedioxymethamphetamine (MDMA, the main active ingredient of ecstasy)) are involved, whereas in ∼60% multiple drugs are involved. These drugs induce higher dopamine and serotonin levels resulting in...

Discriminative stimulus effects of N,N-diisopropyltryptamine.

Psychopharmacology March 1, 2013 Theresa M. Carbonaro, Michael J Forster, Michael B. Gatch

Serotonergic hallucinogens such as (+)-lysergic acid diethylamide (LSD) and dimethyltryptamine (DMT) produce distinctive visual effects, whereas the synthetic hallucinogen N,N-diisopropyltryptamine (DiPT) is known for its production of auditory distortions. This study compares the discriminative stimulus effects of DiPT to those of visual hallucinogens. Adult male rats were trained to...

Salvia divinorum: a psychopharmacological riddle and a mind-body prospect.

Current Drug Abuse Reviews March 1, 2013 José-luis Díaz 17 citations

The multidisciplinary research on Salvia divinorum and its chemical principles is analyzed concerning whether the ethnobotany, phytochemistry, mental effects, and neuropharmacology of this sacred psychoactive plant and main principle clarify its experienced effects and divinatory uses. The scientific pursuit spans from the traditional practices, continues with the botanical identification,...

Epidemiology of adolescent Salvia divinorum use in Canada.

Drug and Alcohol Dependence February 1, 2013 Cheryl L Currie 19 citations

Salvia divinorum is a potent, naturally occurring hallucinogen gaining popularity as a recreational drug in North America. To date, detailed epidemiologic information about the use of this substance among adolescents living outside the United States has been limited. This study provides information on the prevalence and correlates of Salvia divinorum use among adolesecents in Canada using a...

DOI: 10.1016/j.drugalcdep.2012.08.008 (opens in new tab) Full text (opens in new tab) Salvia divinorum use Hallucinogen use Lifetime use Past year use +18